Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glanzmann's Disease”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Early research (Phase 1)Study completedNCT02461563
What this trial is testing

A Multiple-Dose Study to Evaluate MK-1075 in Hepatitis C Virus (HCV) Infected Participants (MK-1075-004)

Who this might be right for
Hepatitis C Virus Infection
Merck Sharp & Dohme LLC 12
Large-scale testing (Phase 3)Ended earlyNCT02504099
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcinoma

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 3
Testing effectiveness (Phase 2)Looking for participantsNCT07136857
What this trial is testing

Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531)

Who this might be right for
Glanzmann Thrombasthenia
Emory University 6
Testing effectiveness (Phase 2)Study completedNCT01054729
What this trial is testing

Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients

Who this might be right for
Hepatitis C
Gilead Sciences 64
Testing effectiveness (Phase 2)Study completedNCT01849562
What this trial is testing

Safety, Tolerability, and Efficacy of 12-weeks of Sovaprevir, ACH-3102, and Ribavirin in Treatment-naive GT-1 HCV Participants

Who this might be right for
Hepatitis C, Chronic
Alexion Pharmaceuticals, Inc. 30
Not applicableEnrolling By InvitationNCT06820515
What this trial is testing

ATHNdataset Registry

Who this might be right for
HemophiliaThrombosisHemophilia A+6 more
American Thrombosis and Hemostasis Network 200,000
Large-scale testing (Phase 3)UnknownNCT01457937
What this trial is testing

Boceprevir/PegIFN α-2b/Riba in HCV+ Gt1 Menopausal Women, Nonresponders to PegIFN/Riba or Treatment-naives (MEN_BOC)

Who this might be right for
Chronic Hepatitis CMenopause
University of Modena and Reggio Emilia 240
Post-approval studies (Phase 4)UnknownNCT03037151
What this trial is testing

Safety and Efficacy of Grazoprevir and Elbasvir for GT1ang GT6 With and Without HIV

Who this might be right for
Compensated Cirrhosis
The HIV Netherlands Australia Thailand Research Collaboration 100
Large-scale testing (Phase 3)Study completedNCT02105688
What this trial is testing

An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus (HCV) Genotype (GT)1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 301
Not applicableStudy completedNCT03409731
What this trial is testing

Absorb GT1 Japan PMS

Who this might be right for
Ischemic Heart DiseaseAngina PectorisCoronary Artery Disease+2 more
Abbott Medical Devices 135
Large-scale testing (Phase 3)Study completedNCT01768286
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 441
Not applicableStudy completedNCT00697320
What this trial is testing

Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany

Who this might be right for
Congenital Bleeding DisorderCongenital FVII DeficiencyGlanzmann's Disease+2 more
Novo Nordisk A/S 64
Early research (Phase 1)Study completedNCT01561417
What this trial is testing

Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects

Who this might be right for
Acquired Bleeding DisorderAcquired HaemophiliaCongenital Bleeding Disorder+5 more
Novo Nordisk A/S 28
Testing effectiveness (Phase 2)Study completedNCT00774397
What this trial is testing

Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2)

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 719
Testing effectiveness (Phase 2)Study completedNCT02133131
What this trial is testing

Efficacy and Safety of Grazoprevir (MK-5172), Elbasvir (MK-8742), and Sofosbuvir for Chronic Infection With Hepatitis C Virus Genotypes 1 and 3 (MK-5172-074)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 143
Not applicableWithdrawnNCT02943616
What this trial is testing

ABSORB Post-Approval Clinical Study

Who this might be right for
Ischemic Heart Disease
Abbott Medical Devices
Large-scale testing (Phase 3)Study completedNCT02105701
What this trial is testing

Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068)

Who this might be right for
Hepatitis C Infection
Merck Sharp & Dohme LLC 420
Large-scale testing (Phase 3)Study completedNCT01851330
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 647
Post-approval studies (Phase 4)Study completedNCT00926614
What this trial is testing

Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba

Who this might be right for
Hepatitis c
Brooke Army Medical Center 20
Large-scale testing (Phase 3)Study completedNCT02358044
What this trial is testing

Efficacy and Safety of Combination Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Sofosbuvir + Pegylated Interferon + Ribavirin in Hepatitis C Virus Genotype 1, 4 or 6 Infection (MK-5172-077)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 257
Load More Results